Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women.

Aydin H, Mutlu N, Akbas NB.

J Psychiatr Res. 2011 Oct;45(10):1316-20. doi: 10.1016/j.jpsychires.2011.04.005. Epub 2011 May 4.

PMID:
21531430
2.

Relation of cortisol levels and bone mineral density among premenopausal women with major depression.

Altindag O, Altindag A, Asoglu M, Gunes M, Soran N, Deveci Z.

Int J Clin Pract. 2007 Mar;61(3):416-20.

PMID:
17313608
3.

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.

Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.

J Bone Miner Res. 1996 Mar;11(3):337-49.

PMID:
8852944
4.

Bone mineral density in premenopausal women with major depression.

Yazici AE, Bagis S, Tot S, Sahin G, Yazici K, Erdogan C.

Joint Bone Spine. 2005 Dec;72(6):540-3. Epub 2005 Jun 23.

PMID:
16046174
5.

Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.

Adami S, Zivelonghi A, Braga V, Fracassi E, Gatti D, Rossini M, Ulivieri FM, Viapiana O.

Bone. 2010 Jan;46(1):244-7. doi: 10.1016/j.bone.2009.10.011. Epub 2009 Oct 21.

PMID:
19853071
6.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
7.

Effect of acute citrate load on markers of bone metabolism in healthy volunteers.

Chen Y, Bieglmayer C, Höcker P, Dettke M.

Vox Sang. 2009 Nov;97(4):324-9. doi: 10.1111/j.1423-0410.2009.01202.x. Epub 2009 Jun 9.

PMID:
19508702
8.

Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.

Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R.

J Bone Miner Res. 1995 Dec;10(12):1844-52.

PMID:
8619364
9.

Bone density and depression in premenopausal South African women: a pilot study.

Govender C, Du Plessis AM, Bipath P, Povey D, Viviers G, Viljoen M.

Afr J Psychiatry (Johannesbg). 2010 Mar;13(1):58-60.

PMID:
23155514
10.
11.

Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women.

Desai MP, Bhanuprakash KV, Khatkhatay MI, Donde UM.

J Clin Lab Anal. 2007;21(2):55-60.

PMID:
17385673
12.

Weight loss-induced alterations in serum markers of bone turnover persist during weight maintenance in obese men and women.

Hinton PS, LeCheminant JD, Smith BK, Rector RS, Donnelly JE.

J Am Coll Nutr. 2009 Oct;28(5):565-73.

PMID:
20439552
13.

No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitudinal study.

Kaya MC, Bez Y, Selek S, Fatih Karababa I, Bulut M, Savaş HA, Celik H, Herken H.

Arch Med Res. 2012 May;43(4):294-7. doi: 10.1016/j.arcmed.2012.05.006. Epub 2012 Jun 13.

PMID:
22704847
14.

Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

Kilts CD, Wade AG, Andersen HF, Schlaepfer TE.

Expert Opin Pharmacother. 2009 Apr;10(6):927-36. doi: 10.1517/14656560902849258 .

PMID:
19317630
15.

Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.

Peichl P, Griesmacher A, Müller MM, Marteau R, Kumpan W, Bröll H.

Gynecol Endocrinol. 2000 Oct;14(5):374-81.

PMID:
11109977
16.

[The effect of levothyroxine suppression therapy for benign thyroid nodules on bone metabolism in premenopausal women].

Akinci B, Demir T, Cömlekçi A, Karaoğlu O, Seçil M, Yeşil S.

Kulak Burun Bogaz Ihtis Derg. 2008 Jul-Aug;18(4):232-7. Turkish.

PMID:
19052491
17.

Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.

Pae CU, Mandelli L, Han C, Ham BJ, Masand PS, Patkar AA, Steffens DC, De Ronchi D, Serretti A.

Neuro Endocrinol Lett. 2008 Aug;29(4):500-6.

PMID:
18766158
18.

Determinants of bone turnover markers in healthy premenopausal women.

Adami S, Bianchi G, Brandi ML, Giannini S, Ortolani S, DiMunno O, Frediani B, Rossini M; BONTURNO study group.

Calcif Tissue Int. 2008 May;82(5):341-7. doi: 10.1007/s00223-008-9126-5. Epub 2008 May 10.

PMID:
18470550
19.

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.

van Zyl LT, Lespérance F, Frasure-Smith N, Malinin AI, Atar D, Laliberté MA, Serebruany VL.

J Thromb Thrombolysis. 2009 Jan;27(1):48-56. doi: 10.1007/s11239-007-0189-3. Epub 2008 Jan 11.

PMID:
18188512
20.

Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.

Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.

Maturitas. 2007 Mar 20;56(3):288-96. Epub 2006 Oct 9.

PMID:
17030103

Supplemental Content

Support Center